olmesartan medoxomil + hydrochlorothiazide, if necessary

DRUG3 trials

Sponsors

Daiichi Sankyo, Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company

Conditions

Essential HypertensionHypertensionIsolated Systolic Hypertension

Phase 3

Isolated Systolic Hypertension in the Elderly and Very Elderly

CompletedNCT00751829

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyIsolated Systolic Hypertension

Start: 2003-07-31End: 2005-02-28Updated: 2023-06-01

Olmesartan Medoxomil Versus Losartan in Elderly and Very Elderly

CompletedNCT00751751

Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo CompanyEssential Hypertension

Start: 2003-06-30End: 2005-06-30Updated: 2008-09-12

Phase 4

A Study of the Blood Pressure Lowering Ability and Safety of Olmesartan Medoxomil in Stage I and Stage II Hypertension

CompletedNCT00430638

Daiichi SankyoHypertension

Start: 2006-12-31End: 2007-10-31Updated: 2018-10-02